New York, NY -- (SBWIRE) -- 12/06/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Adamis Pharmaceuticals Corp (OTCMKTS:ADMP), DURECT Corporation (NASDAQ:DRRX), Hecla Mining Company (NYSE:HL), Applied Materials, Inc (NASDAQ:AMAT)
Adamis Pharmaceuticals Corp (OTCMKTS:ADMP) showed a volume of 812,189.00 shares by the end of last trade whereas the average volume of the stock remained 175,373.00 shares. The stock opened the session at $0.50but then moved to $0.700. At that price, the stock showed a positive performance of 40.00%. Adamis Pharmaceuticals Corporation (Adamis), formerly Cellegy Pharmaceuticals, Inc.operates through its wholly owned subsidiaries Cellegy Holdings, Inc., Adamis Corporation and Biosyn, Inc. Adamis Corporation has two wholly owned subsidiaries: Adamis Viral Therapies, Inc. (Adamis Viral) and Adamis Laboratories, Inc. (Adamis Labs). Adamis Labs is a specialty pharmaceutical company. The Company focuses on developing and commercializing products in the anti-inflammatory,
Will ADMP Continue To Move Higher? Find Out Here
DURECT Corporation (NASDAQ:DRRX) opened the session at $1.60 and closed the session at $1.57. The stock showed a negative performance of -2.48% in previous trading session. Traded with volume of 1.05 million shares in the prior session and the average volume of the stock remained 598,061.00 shares. Durect Corporation is a specialty pharmaceutical company focused on the development of pharmaceutical products based on its drug delivery technology platforms. The Company’s product pipeline, as of December 31, 2012, consisted of eight investigational drug candidates in clinical development, with one program the subject of a New Drug Application (NDA) with the United States Food and Drug Administration (FDA), with one program in Phase III with an NDA in preparation, two programs in Phase II and three programs in Phase I. The Company’s products candidates include Remoxy, POSIDUR, ELADUR,
Has DRRX Found The Bottom And Ready To Gain Momentum? Find Out Here
Hecla Mining Company (NYSE:HL) opened the session at $2.76 and closed the session at $2.80. The stock showed a negative performance of -1.06% in previous trading session. Traded with volume of 14.82 million shares in the prior session and the average volume of the stock remained 4.39 million shares. The beta of the stock remained 2.11. Hecla Mining Company is engaged in discovering, acquiring, developing, producing, and marketing silver, gold, lead and zinc. The Company operates in two segments: the Greens Creek unit and the Lucky Friday unit. Its wholly-owned subsidiary is Hecla Alaska LLC. The Company produces zinc, lead and bulk concentrates at its Greens Creek unit and lead and zinc concentrates at its Lucky Friday unit, which it sells to custom smelters on contract,
Why Should Investors Buy HL After the Recent Fall? Just Go Here and Find Out
Applied Materials, Inc (NASDAQ:AMAT) the stock decreased -0.66% and finished the session at $16.50. Traded with volume of 4.03 million shares in the prior session and the average volume of the stock remained 10.62 million shares. The beta of the stock remained 1.38. Applied Materials, Inc. (Applied) provides manufacturing equipment, services and software to the global semiconductor, flat panel display, solar photovoltaic (PV) and related industries. Applied’s customers include manufacturers of semiconductor wafers and chips, flat panel liquid crystal displays (LCDs), solar PV cells and modules, and other electronic devices.
Will AMAT Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)